NovaBay Pharmaceuticals Inc. Announces Special Dividend, Stock Soars
NovaBay Pharmaceuticals Inc., a biopharmaceutical company specializing in the topical anti-infective market, has recently announced a significant financial move that has positively impacted its stock performance. On August 26, 2025, NovaBay declared a one-time special cash dividend of $0.80 per share, as reported by multiple financial news sources including Seeking Alpha and GlobeNewswire.
Following the announcement, NovaBay’s stock experienced a substantial rally. According to Benzinga, the stock soared by 48% after hours, reflecting investor enthusiasm over the dividend declaration. TipRanks further highlighted the stock’s impressive performance, noting a 91.33% increase on the day of the announcement.
The dividend is set to be payable on September 29, 2025, to shareholders recorded as of the close of business on September 15, 2025. However, due to the size of the dividend, which exceeds 25% of the value of NovaBay’s stock, the NYSE American has indicated that the stock will trade with due bills. This results in a Dividend Right Period from September 15, 2025, through September 29, 2025.
As of August 26, 2025, NovaBay’s stock closed at $1.55, with a 52-week high of $1.90 and a low of $0.44 recorded on September 9, 2024. The company’s market capitalization stands at approximately $9,026,409 USD.
This strategic financial decision underscores NovaBay’s commitment to returning value to its shareholders while continuing to focus on its core mission of developing innovative solutions for bacterial and fungal infections. Investors are encouraged to stay informed about such developments to make well-informed investment decisions.